UniProt/SwissProt ID: | PTTG1_HUMAN |
Description: | pituitary tumor-transforming 1 [Source:HGNC Symbol;Acc:9690] |
Location: | chr5 q33.3 |
Node attribute: | substrate; gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S165 | QLGPPsPVKMP | CDC2(CDK1 | RegPhos |
S171 | PVKMPsPPWES | Securin | PhosphoSitePlus |
T43 | RSQVStPRFGK | Securin | PhosphoSitePlus |
S42 | GRSQVsTPRFG | Securin | PhosphoSitePlus |
S184 | LQSPSsILSTL | Securin | PhosphoSitePlus |
S165 | QLGPPsPVKMP | CDK1 | HPRD; phosphoELM |
S39 | ALDGRsQVSTP | Securin | PhosphoSitePlus |
Y111 | ASDDAyPEIEK | Securin | PhosphoSitePlus |
S181 | SNLLQsPSSIL | HPRD | |
T16 | NGEPGtRVVAK | Securin | PhosphoSitePlus |
S165 | QLGPPsPVKMP | CDC2 | RegPhos |
S184 | LQSPSsILSTL | HPRD | |
S28 | GLKLGsGPSIK | Securin | PhosphoSitePlus |
S183 | LLQSPsSILST | Securin | PhosphoSitePlus |
S165 | QLGPPsPVKMP | HPRD; phosphoELM; RegPhos | |
S165 | QLGPPsPVKMP | Securin | PhosphoSitePlus |
Dephosphorylation site |
PTTG1_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000377536 | *203L | COSMIC | Hepatocellular Carcinoma | 21822264 |
ENSP00000344936 | T60N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000430642 | T60N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000377536 | T60N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000430642 | *203L | COSMIC | Hepatocellular Carcinoma | 21822264 |
ENSP00000344936 | *203L | COSMIC | Hepatocellular Carcinoma | 21822264 |
Differential expressed protein |
PTTG1_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
PTTG1_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
CDK1_HUMAN | PTTG1_HUMAN | kinase -> substrate | HPRD; RegPhos |
ZAGL2_HUMAN | PTTG1_HUMAN | kinase -> substrate | RegPhos |
P53_HUMAN | PTTG1_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05166 | HTLV-I infection |
hsa04114 | Oocyte meiosis |
hsa04110 | Cell cycle |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0007283 | spermatogenesis | TAS | biological_process |
GO:0006281 | DNA repair | IEA | biological_process |
GO:0007067 | mitosis | IEA | biological_process |
GO:0051301 | cell division | IEA | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0031145 | anaphase-promoting complex-dependent proteasomal u | TAS | biological_process |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0000278 | mitotic cell cycle | TAS | biological_process |
GO:0017124 | SH3 domain binding | IEA | molecular_function |
GO:0006355 | regulation of transcription, DNA-dependent | TAS | biological_process |
GO:0051276 | chromosome organization | IEA | biological_process |
GO:0006366 | transcription from RNA polymerase II promoter | TAS | biological_process |
GO:0006259 | DNA metabolic process | IEA | biological_process |
GO:0007059 | chromosome segregation | IEA | biological_process |
GO:0003700 | sequence-specific DNA binding transcription factor | TAS | molecular_function |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0004869 | cysteine-type endopeptidase inhibitor activity | NAS | molecular_function |